Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients

Oncology Reports

Volumn 5, Issue 3, 1998, Pages 645-647

  Orditura, Michele ^a,b   De Vita, Ferdinando ^a   Sarubbi, Berardo ^b   Ducceschi, Valentino ^b   Auriemma, Annunziata ^a   Infusino, Stefania ^a   Iacono, Aldo ^b   Catalano, Giuseppe ^a  

^a F Magrassi   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

5 fluorouracil; ECG parameters

Indexed keywords

DOXORUBICIN; FLUOROURACIL; FOLIC ACID; METHOTREXATE;

ADULT; ARTICLE; CANCER PATIENT; CARDIOTOXICITY; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY; FEMALE; HEART ELECTROPHYSIOLOGY; HEART REPOLARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0031980755     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.3.645     Document Type: Article

References (23)

1. Grem JL: Fluorinated Pyrimidines. In: Cancer Chemotherapy, Principles and Practice. Chabner BA and Collins JM (eds). JB Lippincott Co, Philadelphia, pp 197-200, 1990.
2. Yokes EE and Weichselbaum RR: Concomitant chemoradiotherapy: rational and clinical experience in patients with solid tumors. J Clin Oncol 8: 911-934, 1990.
3. Labianca R, Beretta G, Clerici M, Fraschini P and Luporini GI: Cardiotoxicity of 5-Fluorouracil: a study of 1083 patients. Tumori 68: 505-510, 1982.
4. Dent RG and McColl I: 5-Fluorouracil and angina. Lancet i: 347-348, 1975.
5. Akhtar SS, Salim KP and Bono ZA: Sympomatic cardiotoxicity with high-dose 5-Fluorouracil infusion: a prospective study. Oncology 50: 441-444, 1993.
6. Robben NC, Pippas AW and Moore JD: The syndrome of 5-Fluorouracil cardiotoxicity. Cancer 71: 493-509, 1993.
7. Schoeber C, Papageorgiou E, Harstrick A, Bokemeyer C, Mugge A and Sthal M: Cardiotoxicity of 5-Fluorouracil in combination with folinic acid in patients with gastrointestinal cancer. Cancer 72: 2242-2247, 1993.
8. Gradishar WJ and Vokes EE: 5-Fluorouracil cardiotoxicity: a critical review. Ann Oncol 1: 409-414, 1990.
9. Moss AJ and Schwartz PJ: Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias. Mod Concepts Cardiovasc Dis 51: 85-91, 1982.
10. Higham PD, Furniss SS and Campbell RWF: QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J 73: 32-36, 1995.
11. Davey PP, Bateman J, Mulligam IP, Forfar C, Barlow C and Hart G: QT interval dispersion in chronic heart failure and left ventricular hypertrophy: relation to autonomic nervous system and Holter tape abnormalities. Br Heart J 71: 268-273, 1994.
12. Bazett HC: An analysis of the time-relations of electrocardiograms. Heart 7: 353-370, 1920.
13. Sanani S, Spaulding M, Masud A and Canty R: 5-Fluorouracil cardiotoxicity. Cancer Treatment Rep 65: 1123-1125, 1981.
14. Collins C and Weiden PC: Cardiotoxicity of 5-Fluorouracil. Cancer Treat Rep 71: 733-736, 1987.
15. Freeman NJ and Costanza ME: 5-Fluorouracil associated cardiotoxicity. Cancer 61: 36-45, 1988.
16. Baker WP, Dainer P and Lester WM: Ischemia chest pain after 5-fluorouracil therapy for cancer. Am J Cardiol 57: 497, 1986.
17. Kuzel T, Esparaz B, Green D and Kies M: Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 65: 885-889, 1990.
18. De Lucia D, De Vita F, Orditura M, Renis V, Belli A, Conte M, di Grazia M, Iacoviello L, Donati MB and Catalano G: Hypercoagulable state in patients with advanced gastrointestinal cancer: evidence for an acquired resistance to activated protein C. Tumori (In press).
19. Villani F, Guindani A and Pagoni A: 5-Fluorouracil cardiotoxicity. Tumori 66: 635-666, 1982.
20. Schwartz PJ: Idiopatic long QT syndrome: progress and question. Am Heart J 109: 399-411, 1985.
21. Fei L, Goldman JH, Prasad K, Keeling PJ, Reardon K, Camm J and McKenna WJ: QT dispersion and RR variation on 12-lead ECGs in patients with congestive heart failure secondary to idhiopathic dilated cardiomyopathy. Eur Heart J 17: 258-263, 1996.
22. Yunus A, Gillis AM, Duff HJ, Wyse G and Mitchell LB: Increased precordial QTc dispersion predicts ventricular fibrillation during acute myocardial infarction. Eur Heart J 4: 706-708, 1996.
23. Orditura M, Sarubbi B, DeVita F, Ducceschi V, Santangelo L, Cariello A, Iacono A, Catalane G: Prolonged corrected QT dispersion: early sign of doxorubicin cardiotoxicity? Oncol Rep 4: 1047-1050, 1997.